Bruker Posts Strong Q3; Shares Jump | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker today reported strong third-quarter financial results, with its revenues rising around 10 percent year over year.

The Billerica, Mass.-based firm easily beat analysts' consensus estimates for revenues and earnings per share, causing its shares to soar in early Thursday trade on the Nasdaq.

Bruker brought in total revenues of $265.1 million for the three-month period ended Sept. 30, compared to $242.1 million for the third quarter of 2008. Analysts, on average, had expected $240 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.